Director, Business Development for multiple cancer centers in Bakersfield, CA;
Sargas Pharmaceutical Adherence & Compliance International.
Director Business Development
Health care executive with three decades of experience in building relationships with physicians, health professionals. pharmaceutical companies, insurance companies and medical equipment companies. Knowledge in developing various revenue streams like in office dispensing, ancillary services in hospitals, specialty health clinics and cancer centers. Have consulted with various cancer clinics and hospitals around the country for the cancer service line development.
Regularly assisting with reimbursement issues, regulatory environment, financing, mergers, acquisitions, partnerships and collaborations in the health care and pharmaceutical industry. In leisure play golf with my son and get involved in community fund raising for cancer events, religious charities and other community needs. Graduated from Gujarat University in Physics and have attended Cornell and University of Phoenix for further studies in US.
|Ravi Patel, MD FACP
Hematology / Oncology
Ravi Patel, MD is a board certified medical oncologist who has been in active practice for more than twenty years. He founded Comprehensive Blood and Cancer Center (CBCC) and grew it from a 1000 square foot office with one employee into a truly comprehensive, community focused diagnostic, treatment, educational and research based cancer center.
While serving as managing director of the Center, Dr. Patel continues to actively care for his patients and serve as principal investigator on the Center's many clinical research studies....
Dr. Patel is actively involved with the leading pharmaceutical manufactures and academic research programs to assure that cancer patients in Kern County have access to the most cutting edge medicines and treatments available anywhere in the world. His goal is for every patient treated at CBCC to have access to at least one standard cancer therapy and one more advanced treatment regimen, which CBCC makes available through its rigorously managed program of clinical research trials.
To this end, Dr. Patel has chosen to affiliate CBCC with the UCLA School of Medicine. Working through the UCLA research consortium, UCLA employees manage clinical trials along side the Center's own research staff. Several of the treatments tested at the CBCC have proven to be highly successful and have gone on to receive approval from the Federal Government's Food and Drug Administration (FDA). These breakthrough treatments have changed the way that many forms of cancer are now being managed around the world.
As a result of his clinical research experience, Dr. Patel has authored several scientific papers in such respected journals as the Journal of Clinical Oncology and Clinical Lymphoma. He is sought after as a lecturer and consultant on clinical oncology issues and patient care. In this capacity, he serves as an Associate Clinical Professor of Medicine at the University of California at Los Angeles (UCLA). He is actively involved with the Residency Program in Internal Medicine at the Kern County Medical Center.
With over 25 years of pharmacy retail with Walgreens, Wible and Jacob drugs and generic manufacturing experience with Cadilla Pharmaceuticals, he has lead teams of 25 to over 150. Has developed and implemented medication management systems for compliance and adherence for patients.
Developed educational classes for various specialty drugs so that the symptom management is explained and patient can remain engaged in their treatment with physician and pharmacist.
|Ronald R. Barkley
Mr. Barkley is a healthcare business development and operations officer with leadership expertise in medical group practice; clinically integrated network and hospital/health system settings. Ron is passionate about transforming fragmented healthcare services into integrated and accountable systems of care that address the quality, outcome and economic mandates of our healthcare reform environment.
Ron's particular areas of focus include the alignment of community oncologists and hospitals/health systems into comprehensive and integrated oncology service lines and cancer centers and the operational re-engineering and payment re-design of oncology services in preparation for the assumption of financial risk within the context of accountable care initiatives, such as the Oncology ACO and Oncology Medical Home models.
Ron is experienced in medical group practice management having served as Executive Director for a regionally dominant community oncology practice in New England and as market executive for the organizational re-structuring of the Chicago-area practices of the US Oncology Network.
In the hospital and academic medical center setting, Ron served as Managing Director of the for-profit clinical service businesses of a multi-hospital integrated delivery system in Southern California and as business advisor to oncologist-hospital service line consolidations in numerous community settings nationally. Ron also served as transaction and implementation lead in developing and implementing a pioneering community practice-AMC affiliation model with Dana Farber Cancer Institute, Boston.
Mr. Barkley holds a Bachelor's Degree in Life Sciences from Michigan State University; a Master's Degree in Healthcare Administration from California State University and earned his law degree after attending Southwestern University and California College of Law. He is a member of the State Bar of California; American Health Lawyer's Association and Association of Community Cancer Centers and is Co-Chair of the Cancer Center Business Summit (CancerBusinessSummit.com), a national oncology thought leadership forum on matters of oncologist-hospital alignment, business models for integration and market consolidation strategies in oncology/cancer care delivery
Chief Executive Officer
Marin Specialty Care
Harvey D. Bichkoff, M. P. H. practiced hospital administration at both public and private hospitals for many years before joining Marin Oncology Associates in 1995. As Chief Executive Officer at Marin Oncology Associates, he organized California Cancer Care, a large medical group that provided medical oncology services in three San Francisco Bay Area Counties. California Cancer Care was recognized for its superior performance in the Medical Group Management Association’s Performance and Practices of Successful Medical Groups in 2000 and 2005. In 2011, he engineered a merger between the local radiation oncology and urology groups to form Marin Specialty Care. The new organization has developed a strategic partnership with Marin General Hospital to jointly manage the hospital’s cancer program. Bichkoff now serves as both CEO of the medical group and Executive Director of the hospital’s oncology service line.
Mr. Bichkoff is a Past President of the Medical Group Management Association’s Assembly of Hematology/Oncology Administrators. This is the nation’s largest group of oncology administrators. He was formerly the liaison for this group to the American Society of Clinical Oncology (ASCO). Mr. Bichkoff was also a member of ASCO’s Clinical Practice Committee. He was a member of the UC Berkeley Public Health Alumni Association Board of Directors.
Mr. Bichkoff was a member of the Marin General Hospital Transition Committee. He worked on this committee to separate a public hospital to independence from Sutter Health. He remained as a member of the Marin General Hospital Governing Board. He has since left the hospital board and remained on the hospital finance committee. Mr. Bichkoff is a member of the board of the Prima Medical Foundation. This is the largest physician group in Marin County. Bichkoff is also a member of the Meritage ACO Steering Committtee.
He has served as President of the Board of Directors of Healthcare Strategies and Perspectives (HS&P) the largest SF Bay Area networking group for healthcare executives. He engineered the merger of HS&P with the Healthcare Executives of Northern California to form the largest healthcare executives network in the region. Bichkoff is a former member of the United Healthcare Oncology Physician Advisory Board.
Mr. Bichkoff is a surveyor for the Accreditation Association of Ambulatory Healthcare (AAAHC) and was a surveyor for California Medical Association’s Institute for Medical Quality (IMQ). He served on the IMQ’s Ambulatory Review Committee, which is responsible for rendering accreditation decisions for numerous medical groups in California. He advises and consults with numerous Wall Street, pharmaceutical and biotech firms.
He is married with a son and a daughter and enjoys travel, sports and volunteer work.
|Peter D. Eisenberg
Dr. Eisenberg has been active in statewide oncology issues and founded the Association of Northern California Oncologists. He has participated as a member of the American Society of Clinical Oncology committees for more than 20 years and has recently served as a member of ASCO’s Board of Directors as well as a member of the Health Services, Clinical Practice, Ethics and Quality of Care Committees.
Dr. Eisenberg grew up in the Philadelphia area where he attended college and medical school. He trained in internal medicine in Jacksonville, Florida and at Michigan State University. He did a fellowship in hematology and medical oncology in Jacksonville and continued his fellowship at the University of California, San Francisco, where he was on the faculty and performed basic science research.
Dr. Eisenberg has been in private practice for more than 30+ years as a member of the recently formed Marin Specialty Care (a Marin Cancer Care company) – a twelve-physician practice in Marin comprised of medical oncologists, radiation oncologists and urologists.
Dr. Eisenberg has a burning interest in clinical research and, was a leader in Pharma’s move to use networks of community practices to accrue clinical trial subjects. In the past, he was the principal Investigator of a consortium of more the 30 community physicians participating in studies of RTOG, SWOG, and NSABP. He currently administers numerous trials for Marin Cancer Care.
Another interest of Dr. Eisenberg’s is that of clinical outcomes and practice efficiency. His partners are inclined to experiment with their practice style to improve the service they provide. They were recognized by the Institute of Medicine in their October, 2000 monograph, “Enhancing Data Systems to Improve the Quality of Cancer Care.”
Dr. Eisenberg has participated with the NQF’s Cancer Care Quality Measures Steering Committee, the NCI’s Cancer Redesign (CaRe) Planning Group and advisory boards of the Institute of Medicine and RAND.
He is married, has 3 daughters, and loves to travel and participate in outdoor sports.
|Trey L. Noel
Chief Financial Officer
Trey brings a broad background of both strategic and financial decision-support expertise from his past roles in consumer goods, medical products, and health care. Specifically, for the last 9 years, he has held senior leadership positions with McKesson Corporation, managing large pharmaceutical relationships for specialty products, federal government vaccine programs, pharmacy management organizations and traditional supply chain operations.
His operational and strategic exposure position him well to assist smaller organizations develop a strategic path to success. He is currently the CFO of a Nashville TN based emerging Healthcare IT organization focused on the Genetics testing industry.
Trey is a currently a leadership mentor in the Everwise program and Jump Start Foundry and advisor to Octovis Inc, E3 Performance Group and now Sargas Pharmaceutical Compliance and Adherence International.
Trey earned two degrees from Southern Methodist University. He earned his Bachelor of Science in Economics and an MBA from the Cox School of Business. He lives in Brentwood with his wife, Samantha and their 2 sons, Nicolas and Harry and enjoys golf, traveling and coaching youth football and baseball.
Director of financial services & operations
Ricky Newton has over 23 years of experience in the healthcare industry. As Director of Financial Services and Operations, he will provide guidance and support for COA practices in the critical areas of administration, purchasing, billing, and practice management. The ability to benchmark operations and finances is a critical part of the payment reform models proposed by COA and which many practices are adopting.
Previously Ricky was the director of Cancer Specialists of Tidewater, Ltd (CST). Prior to joining the practice he was a CPA with the public accounting firm of Failes & Associates where he spent many years helping physicians negotiate compensation contracts, benchmarking financial data, and using that data to help practices become more efficient.
Mr. Newton also created the AnalyzeIt software that breaks down costs from a practice’s income statement into the costs per CPT code. This allows practices to look at the cost of treating patients in various regimens verses what would be reimbursed for all services including the drugs, labs, and services.
Ricky has presented and consulted at over 350 conferences and practices in 46 states on topics such as financial and practice management issues in medical practices, contracting with insurers, pharmacy management including managing pharmaceutical contracts, and compensation models. His audiences have included physicians, administrators, clinical and administrative staff, and pharmaceutical executives.
Currently, Ricky serves as treasurer of the Virginia Association of Hematology and Oncology Managers (VAHOM), Virginia Association of Hematologists and Oncologist (VAHO), Southeastern Coalition of Oncology Practitioner (SCOOP) and Community Oncology Alliance (COA).
Ricky graduated with honors in 1990 from Old Dominion University with majors in Accounting and Finance.
Ravi Patel, MD FACP
Hematology/Oncology Medical Director
Show Biodata >>
Peter D. Eisenberg
M.D., FACP Show Biodata >>